Company profile
Exogenix
Clinically regulated exosome biologics developed under FDA IND standards for regenerative, aesthetic, and orthopedic use
- Industry
- Biotechnology Research
- Employees
- 6
Exogenix company summary
Exogenix is a company in the Biotechnology Research industry. On LinkedIn the company has around 6 employees. Its listed specialties include regenerative medicine, aesthetics, stem cell, pain management, exosomes.
What technology does Exogenix use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Exogenix
Next-Generation Exosome Therapeutics | FDA-Aligned | Clinical-Grade | Global Distribution Description: Exogenix is redefining standards in regenerative medicine by providing the only exosome-based injectable biologic manufactured under a 351(a) FDA pathway with an active FDA Master File. Unlike topical serums or research-grade exosomes, our biologics are produced with full clinical oversight, GMP standards, and validated potency — delivering 100B+ CD81+ purified exosomes per vial for consistent, scalable patient outcomes. Who We Serve: We support healthcare providers, aesthetic practices, and pain specialists seeking safe, potent, and compliant regenerative therapies. 💡 What Sets Us Apart: ✅ FDA Master File + IND Pathway (351a Drug) ✅ Injectable + Topical options ✅ GMP manufacturing & ISO-5 cleanroom standards ✅ COA-backed, third-party tested, CD81+ purified ✅ Global distribution & provider support Let’s raise the bar for what regenerative medicine should be. 📍Headquartered in Dallas, TX | Serving global clinical markets
Specialties
Compare companies similar to Exogenix
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Exogenix exogenix.com | Biotechnology Research | 6 | - | - |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Exogenix
What does Exogenix do?
Next-Generation Exosome Therapeutics | FDA-Aligned | Clinical-Grade | Global Distribution Description: Exogenix is redefining standards in regenerative medicine by providing the only exosome-based injectable biologic manufactured under a 351(a) FDA pathway with an active FDA Master File. Unlike topical serums or research-grade exosomes, our biologics are produced with full clinical oversight, GMP standards, and validated potency — delivering 100B+ CD81+ purified exosomes per vial for consistent, scalable patient outcomes. Who We Serve: We support healthcare providers, aesthetic practices, and pain specialists seeking safe, potent, and compliant regenerative therapies. 💡 What Sets Us Apart: ✅ FDA Master File + IND Pathway (351a Drug) ✅ Injectable + Topical options ✅ GMP manufacturing & ISO-5 cleanroom standards ✅ COA-backed, third-party tested, CD81+ purified ✅ Global distribution & provider support Let’s raise the bar for what regenerative medicine should be. 📍Headquartered in Dallas, TX | Serving global clinical markets
How many employees does Exogenix have?
Exogenix has around 6 employees on LinkedIn.
Build a lead list from companies like Exogenix
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.